Sponsored by:

Molecular Imaging: Page 317

FDG-PET/CT shows steroid therapy impact on pulmonary nodules
By Wayne Forrest
Monday, November 28 | 11:40 a.m.-11:50 a.m. | SSC14-08 | Room S505ABA pilot study at Children's Hospital of Michigan is seeking to determine whether 40 hours of steroid therapy can help characterize equivocal pulmonary nodules in FDG-PET/CT scans.
November 7, 2011
Study questions SUVmax role in solitary pulmonary nodule malignancy
By Wayne Forrest
Monday, November 28 | 11:20 a.m.-11:30 a.m. | SSC14-06 | Room S505ABResearchers at Thomas Jefferson University are challenging the traditional belief that a decrease in glucose metabolism demonstrated by a solitary pulmonary nodule during the delayed phase of dual-point FDG-PET/CT indicates that the nodule is benign.
November 7, 2011
Novel molecular imaging technique could help prostate cancer patients
By Wayne Forrest
Monday, November 28 | 11:20 a.m.-11:30 a.m. | SSC09-06 | Room S504CDIn this paper presentation, Dutch researchers will show early promising results for two novel molecular imaging techniques to detect and manage lymph node metastases in prostate cancer patients.
November 7, 2011
FDG-PET/CT predicts early response to chemo in NSCLC patients
By Wayne Forrest
Monday, November 28 | 11:00 a.m.-11:10 a.m. | SSC14-04 | Room S505ABFDG-PET/CT is showing its prowess in predicting non-small cell lung cancer (NSCLC) tumor metabolic response and length of survival one and five weeks after the start of chemotherapy treatment.
November 7, 2011
Breast imaging benefits from both PET/CT and PET/MRI
By Wayne Forrest
Sunday, November 27 | 11:05 a.m.-11:15 a.m. | SSA18-03 | Room S505ABBreast imaging can benefit from contrast-enhanced PET/CT, and even better results can be achieved with PET/MRI, according to a study by researchers from Kochi University Hospital in Japan.
November 7, 2011
USP adopts PET drug standards
By AuntMinnie.com staff writers
The U.S. Pharmacopeial Convention (USP) has adopted new quality assurance standards for compounding, producing, and researching PET drugs.
November 6, 2011
PETNet inks pact with Lilly for Amyvid radiotracer
By AuntMinnie.com staff writers
Siemens Healthcare subsidiary PETNet Solutions has signed an agreement with Eli Lilly to manufacture and distribute Lilly's molecular PET imaging agent Amyvid (florbetapir) in the U.S.
November 6, 2011
NorthStar inks NNSA deal for Mo-99
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has signed a $4.6 million agreement with the National Nuclear Security Administration (NNSA) to advance the development of its technology to produce molybdenum-99 (Mo-99) in the U.S. without highly enriched uranium.
November 3, 2011
GE expects gains in molecular imaging
By AuntMinnie.com staff writers
GE Healthcare is looking to double the current annual sales of $2.4 billion in its molecular imaging business segment in the next three to five years.
November 3, 2011
American Shared reports proton therapy progress
By AuntMinnie.com staff writers
Radiosurgery center operator American Shared Hospital Services announced that Mevion Medical Systems is making progress in the development of a compact proton therapy system.
November 2, 2011
More radionuclide therapy needed for bone mets
By AuntMinnie.com staff writers
Prostate cancer patients with bone metastases benefit from repeated administration of radionuclide therapy, according to research published in the November issue of the Journal of Nuclear Medicine.
November 1, 2011
Zecotek crystals make the grade
By AuntMinnie.com staff writers
Nuclear medicine firm Zecotek Photonics said that the newest version of its lutetium fine silicate scintillation crystals has achieved strong results in testing.
October 31, 2011
Previous Page
Page 317 of 612
Next Page